Drug Intelligence Science (DIS®) – A Cutting-Edge Translational Platform Pioneered by HiFiBiO Therapeutics – Featured in Drug Discovery Today
Drug Intelligence Science (DIS®) – Pioneering a High-Resolution Translational Platform to Enhance Probability of Success for Drug Discovery and Development CAMBRIDGE, MA., – October 23, 2023 – HiFiBiO Therapeutics Founder, Chairperson, and CEO Liang Schweizer presents, in the peer-reviewed journal Drug Discovery Today, the company’s proprietary translational platform Drug Intelligence Science (DIS®), highlighting its potential … Continued